SCHEMBL6282634

SCHEMBL6282634

C[Si](C)(C)CCOCn1nc(C=Cc2ccc3c(c2)OCO3)c2c(Nc3cccc([N+](=O)[O-])c3)cccc21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 4/20 0.38
GAA P10253 2/20 0.38
SETD7 Q8WTS6 1/20 0.37
ALDH1A1 P00352 4/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTPN1 P18031 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
METAP2 P50579 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6503644 0.88 AKR1C3 (0.38) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL5249412 0.88 SMN1; SMN2 (0.39) SMN1; SMN2LMNAMAPTGAASETD7
SCHEMBL5249416 0.88 SMN1; SMN2 (0.39) SMN1; SMN2LMNAMAPTGAASETD7
SCHEMBL6286068 0.85 KDM4E (0.39) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL5247154 0.82 SMN1; SMN2 (0.43) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL6492444 0.81 SMN1; SMN2 (0.37) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL5247115 0.81 PTPN1 (0.41) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL5247119 0.81 PTPN1 (0.41) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL6760466 0.80 SMN1; SMN2 (0.38) SMN1; SMN2LMNAMAPTGAAALDH1A1
SCHEMBL6760468 0.80 SMN1; SMN2 (0.38) SMN1; SMN2LMNAMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6891044-B2 Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed